Skip to main content
SpringerLink
Log in

Bulk Disease as the Major Problem in the Cure of Paediatric Sarcomas

  • Conference paper
Pediatric Surgical Oncology

Part of the book series: Progress in Pediatric Surgery ((PEDIATRIC,volume 22))

Abstract

It is a misconception particularly prevalent amongst European paediatric oncologists that, because sarcoma has a propensity to metastasise, therefore only systemic therapy has a major role in management or is logical [1,2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Flamant F, Rodary C, Voute PA, Otten J (1985) Primary chemotherapy in the treatment of rhabdomyosarcoma in children: Trial of the International Society of Pediatric Oncology (SIOP) preliminary results. Radiother Oncol 3:227–236

    Article  PubMed  CAS  Google Scholar 

  2. Otten J, Flamant F, Rodary C, et al (1985) Effectiveness of combination of ifosfamide, vincristine and actinomycin D in inducing remission in rhabdomyosarcoma in children. Proc Am Soc Clin Oncol 4:236 [Abstract C-917]

    Google Scholar 

  3. Skipper HE (1971) Kinetic behavior versus response to chemotherapy. Monogr Natl Cancer Inst 34:2–14

    CAS  Google Scholar 

  4. Skipper HE, Schabel FM, Mellett JB, Montgomery JA, Wilkoff LJ, Lloyd HH, Rockman RW (1970) Implications of biochemical, cytokinetic, pharmacologic and toxicologic relationships in the design of optimal therapeutic schedules. Cancer Chemother Rep 54:431–450

    PubMed  CAS  Google Scholar 

  5. Skipper HE (1978) Cancer chemotherapy 1: Reasons for success and failure of treatment of murine leukaemias with drugs now employed in treating human leukaemias. Ann Arbor University Microfilms International 1978

    Google Scholar 

  6. Baker RM, Ling V (1978) Numbering mutants of mammalian cells in culture. In: Korn ED (ed) Methods in membrane biology. Plenum, New York, pp 337–384

    Chapter  Google Scholar 

  7. Heppner GH, Dexter DL, De Nucci T, Miller FR, Calabres P (1978) Heterogeneity in tumour sensitivity among tumour cell subpopulations of a single mammary tumour. Cancer Res 38:3758–3763

    PubMed  CAS  Google Scholar 

  8. Law LW (1952) Origins of the resistance of leukaemic cells to folic acid antagonists. Nature 169:628–629

    Article  PubMed  CAS  Google Scholar 

  9. Ling V (1978) Genetic aspects of drug resistance in somatic cells. In: Schabel FM (ed) Antibiotics and chemotherapy. Karger, Basel, pp 191–200

    Google Scholar 

  10. Goldie JH, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumours to their spontaneous mutation rate. Cancer Treat Rep 63:172–182

    Google Scholar 

  11. Goldie JH, Coldman AJ, Gudauskas GA (1982) Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66:439–449

    PubMed  CAS  Google Scholar 

  12. Ling V (1975) Drug resistance and membrane alteration in mutants of mammalian cells. Can J Genet Cytol 17:503–515

    PubMed  CAS  Google Scholar 

  13. Steel GG: Growth kinetics of tumours

    Google Scholar 

  14. Griffiths CT, Parker LM, Fuller AF (1979) Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep 63:235–240

    PubMed  CAS  Google Scholar 

  15. Suit HD (1975) Role of therapeutic radiology in cancer of bone. Cancer 35:930–935

    Article  PubMed  CAS  Google Scholar 

  16. Green DM, Jaffe N (1978) Progress and controversy in the treatment of childhood rhabdomyosarcoma. Cancer Treat Rev 5:7–27

    Article  PubMed  CAS  Google Scholar 

  17. Cassady JR, Sagerman RH, Tretter P, Ellesworth RM (1963) Radiation therapy for rhabdomyosarcoma. Radiology 91:116–120

    Google Scholar 

  18. Kingston JE, McElwain TJ, Malpas JS (1983) Childhood rhabdomyosarcoma: Experience of the children’s solid tumour group. Br J Cancer 48:195–207

    Article  PubMed  CAS  Google Scholar 

  19. Sutow WW, Lindberg RD, Gehan EA, et al (1982) Three year relapse-free survival rates in childhood rhabdomyosarcoma of the head and neck. Cancer 49:2217–2221

    Article  PubMed  CAS  Google Scholar 

  20. Hays DM, Raney RB, Lawrence W, Soule EH, Gehan EA, Tefft M (1982) Bladder and prostatic tumours in the intergroup rhabdomyosarcoma study (IRS-1). Cancer 50:1472–1482

    Article  PubMed  CAS  Google Scholar 

  21. Hays DM, Raney RB, Lawrence W, et al (1982) Primary chemotherapy in the treatment of children with bladder-prostate tumours in the intergroup rhabdomyosarcoma study (IRS-2). J Pediatr Surg 17:812–820

    Article  PubMed  CAS  Google Scholar 

  22. Jereb B, Ghavimi F, Exelby P, Zang E (1980) Local control of embryonal rhabdomyosarcoma in children by radiotherapy when combined with chemotherapy. Int J Pediat Oncol Biol Phys 6:825–833

    Google Scholar 

  23. Donaldson S (1985) The value of adjuvant chemotherapy in the management of sarcomas in children. Cancer 55:2185–2197

    Article  Google Scholar 

  24. Ewing J (1921) Diffuse endothelioma of bone. Proc NY Pathol Soc 21:17–24

    Google Scholar 

  25. Fernandez CH, Lindberg RD, Sutow WW, Samuels ML (1974) Localised Ewing’s sarcoma treatment and results. Cancer 34:143–148

    Article  PubMed  CAS  Google Scholar 

  26. Chabora BM, Rosen G, Chan W, D’Angio GJ, Tefft M (1976) Radiotherapy of Ewing’s sarcoma. Radiology 120:667–671

    PubMed  CAS  Google Scholar 

  27. Rosen G, Caparros B, Nirenberg A, et al (1981) Ewing’s sarcoma: ten year experience with adjuvant chemotherapy. Cancer 47:2204–2213

    Article  PubMed  CAS  Google Scholar 

  28. Thomas PRM, Foulkes MA, Gilula LA, et al (1983) Primary Ewing’s sarcoma of the ribs. A report from the Intergroup Ewing’s Sarcoma Study. Cancer 51:1021–1027

    Article  PubMed  CAS  Google Scholar 

  29. Li WK, Lane JM, Rosen G, et al (1983) Pelvic Ewing’s sarcoma. J Bone Joint Surg 65-A:738–747

    Google Scholar 

  30. Thomas PRM, Perez CA, Neff JR, Nesbit ME, Evans RG (1984) The management of Ewing’s sarcoma: Role of radiotherapy in local tumour control. Cancer Treat Rep 68:703–710

    PubMed  CAS  Google Scholar 

  31. Jürgens H, Gobel V, Etspuler G, et al (1985) Factors influencing the prognosis of children and adolescents with primary Ewing’s sarcoma of bone. Proc Am Soc Clin Oncol 4:239 [Abstract C-929]

    Google Scholar 

  32. Perez CA, Tefft M, Nesbit M, et al (1981) The role of radiation therapy in the management of non-metastatic Ewing’s sarcoma of bone. Report of the Intergroup Ewing’s sarcoma study. Int J Radiat Oncol Biol Phys 7:141–149

    Article  PubMed  CAS  Google Scholar 

  33. Tefft M, Razek A, Perez C, et al (1978) Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing’s sarcoma of pelvic bones. Int J Radiat Oncol Biol Phys 4:367–372

    PubMed  CAS  Google Scholar 

  34. Perez CA, Razek A, Tefft M, et al (1977) Analysis of local tumour control in Ewing’s sarcoma. Cancer 40:2864–2873

    Article  PubMed  CAS  Google Scholar 

  35. Pomeroy TC, Johnson RE (1975) Prognostic factors for survival in Ewing’s sarcoma. Am J Roentgenol 123:598–606

    CAS  Google Scholar 

  36. Rosen G (1987) Primary Ewing’s sarcoma. The multidisciplinary lesion. Int J Radiat Oncol Biol Phys 4:527–532

    Google Scholar 

  37. Rosen G, Caparros B, Mosende C, McCormick B, Huvos AG, Marcove RC (1978) Curability of Ewing’s sarcoma and considerations for future therapeutic trials. Cancer 41:888–899

    Article  PubMed  CAS  Google Scholar 

  38. Plowman PN, Shand WS, Jackson DB (1984) Use of absorbable mesh to displace bowel and avoid radiation enteropathy, during therapy of pelvic Ewing’s sarcoma. Human Toxicol 3:229–237

    Article  CAS  Google Scholar 

  39. Lewis RJ, Marcove RC, Rosen G (1977) Ewing’s sarcoma — functional effects of radiation therapy. J Bone Joint Surg 59:325–331

    PubMed  CAS  Google Scholar 

  40. Jentzsch K, Binder H, Cramer H (1981) Leg function after radiotherapy for Ewing’s sarcoma. Cancer 47:1267–1278

    Article  PubMed  CAS  Google Scholar 

  41. Tefft M, Chabora B, Rosen G (1977) Radiation in bone sarcomas. A re-evaluation in the era of intensive systemic chemotherapy. Cancer 39:806–816

    Article  PubMed  CAS  Google Scholar 

  42. Suit HD (1975) Role of therapeutic radiology in cancer of bone. Cancer 35:930–935

    Article  PubMed  CAS  Google Scholar 

  43. Ong RL, Jereb B, Caparros B, Exelby P (1984) Re-defined role of radiation in combined treatment of Ewing’s sarcoma. Int J Radiat Oncol Biol Phys [Suppl 2] 10:170 [Abstract 1048]

    Google Scholar 

  44. Jaffe N, Farber S, Traggis D, et al (1973) Favourable response of osteogenic sarcoma to high dose methotrexate with citrovorum rescue and radiation therapy. Cancer 31:1367–1375

    Article  PubMed  CAS  Google Scholar 

  45. Rosen G (1976) Management of malignant bone tumours. In: Evans AE, D’Angio GJ, Koop CE (eds) Pediatric clinics of North America. Saunders, Philadelphia, p 183

    Google Scholar 

  46. Rosen G, Caparros B, et al (1982) Pre-operative chemotherapy for osteogenic sarcoma. Selection of post-operative adjuvant chemotherapy based on the response of the primary tumour to pre-operative chemotherapy. Cancer 41:1221–1230

    Article  Google Scholar 

  47. Eilber FR, Eckardt J (1985) Adjuvant therapy for osteogenic sarcoma: a randomised prospective trial. Proc Am Soc Clin Oncol 4:144 [Abstract C-561]

    Google Scholar 

  48. Link M, Goorin A, Miser A, et al (1985) The role of adjuvant chemotherapy in the treatment of osteosarcoma of the extremity: preliminary results of the multi-institutional osteosarcoma study. Proc Am Soc Clin Oncol 4:237 [Abstract C-924]

    Google Scholar 

  49. Morton DL, Storm FK, Eilber FR (1985) Surgical management and limb salvage in osteogenic sarcoma. In: D’Angio GJ, Evans AE (eds) Bone tumours and soft tissue sarcomas. Arnold, London, pp 134–139

    Google Scholar 

  50. Plowman PN (1985) Radiotherapy. In: Zingg EJ, Wallace DMA (eds) Bladder cancer. Berlin Heidelberg New York, pp 207–221

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Radiotherapy and Oncology, St. Bartholomew’s Hospital, West Smithfield, London, EC1, UK

    P. N. Plowman

  2. The Hospital for Sick Children, Great Ormond Street, London, WC1N 3HJ, UK

    P. N. Plowman

Authors
  1. P. N. Plowman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Child Health, University of London, Hospital for Sick Children, Great Ormond Street, 30 Guilford Street, GB-London, WC1N 1EH, England

    Lewis Spitz PhD, FRCS (Nuffield Professor of Pediatric Surgery) (Nuffield Professor of Pediatric Surgery)

  2. Chirurgische Abteilung des Mautner Markhof’sehen, Kinderspitals der Stadt Wien, Baumgasse 75, 1030, Vienna, Austria

    Peter Wurnig

  3. Kinderchirurgische Klinik im Dr. von Haunerschen Kinderspital, Universität München, Lindwurmstraße 4, 8000, Münich 2, Germany

    Thomas A. Angerpointner

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Plowman, P.N. (1989). Bulk Disease as the Major Problem in the Cure of Paediatric Sarcomas. In: Spitz, L., Wurnig, P., Angerpointner, T.A. (eds) Pediatric Surgical Oncology. Progress in Pediatric Surgery, vol 22. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72643-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72643-9_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-72645-3

  • Online ISBN: 978-3-642-72643-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation